QualTek Molecular Laboratories
QualTek Molecular Laboratories is a privately held, CAP/CLIA-accredited clinical laboratory founded in 1997 in Santa Barbara, California, providing immunohistochemistry (IHC) services to the research and diagnostic market.
- Company typePrivate
- Founded1997
- HeadquartersSanta Barbara, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What QualTek Molecular Laboratories does
QualTek Molecular Laboratories is a privately held, for-profit laboratory founded in 1997 and headquartered in Santa Barbara, California. According to the supplied firmographic record, the company is described as a provider of immunohistochemistry (IHC) services and holds CAP/CLIA accreditation — credentials that permit the operation of a clinical laboratory performing anatomic pathology assays on patient specimens for diagnostic and research purposes. Beyond this scope, no additional product lines, technology stack, service menu, or operational details specific to QualTek are disclosed in the input data.
The input corpus does not provide verifiable information about QualTek's customer base, revenue, headcount, leadership beyond the founder/CEO designation, pricing, distribution channels, or strategic moves. The ownership commentary in the source explicitly notes that the bulk of the aggregated material pertains to Discovery Life Sciences (dls.com), a separate entity, and warns against conflating the two. Consequently, any inference about QualTek's go-to-market motion, technology platform, or revenue mechanics beyond the single confirmed fact (CAP/CLIA-accredited IHC service provider) would not be grounded in the provided evidence. The only directly attested business attribute is that QualTek has operated continuously as an IHC-focused clinical laboratory since 1997 under the leadership of founder Steven A. Bernstein.
QualTek Molecular Laboratories firmographics
Firmographics- Name
- QualTek Molecular Laboratories
- Website
- https://qmlabs.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- QualTek Molecular Laboratories is a privately held, CAP/CLIA-accredited clinical laboratory founded in 1997 in Santa Barbara, California, providing immunohistochemistry (IHC) services to the research and diagnostic market.
- Ownership category
- akta.pro rank
QualTek Molecular Laboratories industry classification
Industry- Product category
- Clinical Laboratory Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)
- akta.pro secondary industry
- Reference & Esoteric Testing Laboratories (HLAFAMAJ)
Keywords
Where QualTek Molecular Laboratories is headquartered
LocationHeadquarters
- HQ city
- Santa Barbara
- HQ country
- United States
- HQ region
- North America
Markets served
QualTek Molecular Laboratories business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Biospecimen Products: Sale of assay-ready biospecimens including viable cells, tissues, blood products, FFPE samples, and cell therapy starting materials. One-time transactional purchases with prospective collection capabilities.
- Specialty Laboratory Services: Multi-omic lab services including genomics (WGS, RNA-Seq, exome sequencing, single cell), proteomics (Olink, mass spec), molecular pathology (IHC, multiplex IF, spatial biology), and cell biology services (flow cytometry, cell sorting, live-cell imaging).
- Gentest ADME Products and Services: In vitro preclinical products including hepatocytes, microsomes, Supersomes, TransportoCells for drug metabolism and pharmacokinetic studies. Includes enzyme induction/inhibition, reaction phenotyping, and transporter interaction testing services.
- Clinical Trial Services: HLA typing, companion diagnostic CDx services, clinical trial testing, preclinical/translational studies, assay development, and target expression screening for clinical trials.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
QualTek Molecular Laboratories product offering
Product offeringCore offering
QualTek Molecular Laboratories is a CAP/CLIA-accredited provider of immunohistochemistry (IHC) services operating a clinical diagnostics laboratory in Santa Barbara, California. The company executes IHC staining and pathology-based biomarker assays for clients who require regulated, accredited laboratory output for clinical and research purposes.
Differentiator
Problem solved
Functional benefit
Products and services
- Immunohistochemistry (IHC) Services CAP/CLIA-accredited immunohistochemistry assays, including antibody-based tissue staining and pathologist-led interpretation, performed for clinical and research clients.
Quantifiable outcome
- Over 1,200 IND-enabling studies supported by Gentest solutions
Companies that use QualTek Molecular Laboratories
Customer profileSegments4 records
Ideal customer profiles1 record
QualTek Molecular Laboratories technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
QualTek Molecular Laboratories partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- PathAIcorePathAI partners with Discovery Life Sciences to deploy first AI-powered biospecimen solutions. This partnership integrates PathAI's AI pathology technology with Discovery's biospecimen inventory and characterization capabilities to enhance precision medicine research.
- DNAnexuscoreDNAnexus and Discovery Life Sciences partnership to streamline precision health data analysis. Integrates Discovery's multi-omic lab services and biospecimen data with DNAnexus's cloud-based genomic data platform for enhanced bioinformatics capabilities.
- HudsonAlpha Institute for BiotechnologycoreHudsonAlpha is featured on Discovery Life Sciences website. HudsonAlpha is a genomics research institute and Discovery partner for advancing genomic research and clinical applications.
Scale indicators3 records
Recent moves1 record
QualTek Molecular Laboratories competitors and assessment
Company assessmentBroad incumbents
- Sonic Healthcare USA: Network of clinical and anatomic pathology labs including specialty IHC services. Comparable as a multi-site pathology operator with IHC capability at larger scale than QualTek.
- Foundation Medicine: Large oncology molecular profiling lab (now part of Roche) that includes IHC and broader molecular assays. Comparable as a higher-scale incumbent in oncology diagnostic testing that competes for the same biopharma and clinical demand.
- Quest Diagnostics: National clinical reference laboratory with an extensive IHC and anatomic pathology menu. Comparable as a scaled incumbent that competes for the same hospital and oncology IHC volume.
- Laboratory Corporation of America (LabCorp): National clinical reference laboratory with broad IHC and specialty testing capabilities. Comparable as a scaled incumbent competing for the same IHC and anatomic pathology demand.
Emerging players
- Personalis: Molecular diagnostics company with oncology-focused assays, including IHC-adjacent tumor profiling for biopharma and clinical research. Comparable as a smaller, oncology-focused lab competing for adjacent biomarker testing demand.
- Tempus AI: AI-enabled precision medicine company combining molecular profiling, IHC, and clinical data for oncology. Comparable as a specialty lab with multi-omic capabilities targeting the same biopharma and oncology customer base.
Direct peers
- PhenoPath Laboratories: Specialty anatomic pathology and IHC reference laboratory. Closely comparable as a small, IHC-focused clinical lab serving hospital and oncology clients.
- Caris Life Sciences: Molecular pathology and IHC services provider focused on oncology profiling for clinicians and biopharma. Comparable as a specialty lab combining IHC with broader molecular offerings for the same end customers.
- NeoGenomics Laboratories: Specialty oncology-focused clinical laboratory with a strong IHC and molecular pathology franchise serving hospitals, oncologists, and biopharma. Directly comparable as a specialty clinical lab with IHC at the core of its menu.
- Acupath Laboratories: Specialty anatomic pathology and IHC reference lab serving dermatology, urology, and gastroenterology practices. Comparable as a niche IHC and histology services provider.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat2 records
Key risks4 records
Key highlights4 records
Customer concentration
QualTek Molecular Laboratories social profiles
Digital presenceQualTek Molecular Laboratories financial estimates
Financial estimateRevenue estimate
Valuation estimate
QualTek Molecular Laboratories leadership team
Management profileNumber of profiles
Profiles1 record
QualTek Molecular Laboratories funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
QualTek Molecular Laboratories M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about QualTek Molecular Laboratories
What does QualTek Molecular Laboratories do?
QualTek Molecular Laboratories is a CAP/CLIA-accredited provider of immunohistochemistry (IHC) services operating a clinical diagnostics laboratory in Santa Barbara, California. The company executes IHC staining and pathology-based biomarker assays for clients who require regulated, accredited laboratory output for clinical and research purposes.
When was QualTek Molecular Laboratories founded?
QualTek Molecular Laboratories was founded in 1997. It employs 11 to 50 people.
Where is QualTek Molecular Laboratories based?
QualTek Molecular Laboratories is headquartered in Santa Barbara, United States, in the North America region.
How does QualTek Molecular Laboratories make money?
Four revenue lines are on record. Biospecimen Products are the primary driver. The others are specialty Laboratory Services, gentest ADME Products and Services and clinical Trial Services.
Who are QualTek Molecular Laboratories's main competitors?
Broad incumbents on record are Sonic Healthcare USA, Foundation Medicine, Quest Diagnostics and Laboratory Corporation of America (LabCorp). Emerging players are Personalis and Tempus AI. Direct peers are PhenoPath Laboratories, Caris Life Sciences, NeoGenomics Laboratories and Acupath Laboratories.
Does QualTek Molecular Laboratories have an API?
No public API is recorded for QualTek Molecular Laboratories.
What industry is QualTek Molecular Laboratories in?
QualTek Molecular Laboratories's product category is Clinical Laboratory Services. Its primary akta.pro industry code is HLAFAMAB, Clinical Chemistry & Immunoassay Laboratories, with a secondary code of HLAFAMAJ, Reference & Esoteric Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.